• 繁

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    BASF (XTRA:BAS) Stock Gains A Profit Jolt While Cash Remains Elusive

    Simply Wall St·07/30/2026 19:16:48
    語音播報

    BASF stock came into this earnings day with a solid rebound behind it, up about 9.5% over the past month. However, the real story is what sits under the hood. The market is reacting to a chemicals giant that just reported a very sharp swing in profitability, helped by a €3.5b after tax gain from the Coatings sale.

    The emotional tug of war is clear. Bulls are focusing on a 54% jump in Q2 EBITDA before special items to €2.4b and a higher full year EBITDA target. Skeptics are watching negative free cash flow and asking how durable this profit mix really is.

    Is BASF trading at a genuine discount, or are weak cash flows and dividend coverage quietly telling a different story? Compare the current share price against our detailed valuation analysis for BASF

    Q2 2026 Earnings Summary

    • Revenue (Q2 2026 vs. Q2 2025): €17,206m vs. €14,788m (around 16% higher)
    • Net Income Excluding Extra Items (Q2 2026 vs. Q2 2025): €579m vs. loss of €1m (returned to profit)
    • Basic EPS (Q2 2026 vs. Q2 2025): €0.67 vs. loss of €0.00 (moved from roughly breakeven to positive earnings per share)
    • Earnings From Discontinued Operations (Q2 2026 vs. Q2 2025): €3,565m vs. €80m (a very large one off boost from disposals, including the Coatings sale)

    Prefer clean visual charts over scrolling through dense tables of BASF figures? See BASF's full financial picture, including a clear view of its dividend history and how it lines up with earnings and cash flows in our company report for BASF.

    XTRA:BAS Trailing 12-Month Earnings & Revenue History as at Jul 2026
    XTRA:BAS Trailing 12-Month Earnings & Revenue History as at Jul 2026

    BASF earnings: progress on profit levers, cash still lags

    Bulls argue BASF is moving faster on operational improvement than expected, with cost savings, new sites and higher value segments driving earnings. Q2 and first half numbers give this view some support. EBITDA before special items reached €2.4b in Q2 and €4.8b for the first half, helped by volume growth in Greater China, price increases and better contribution margins in Materials, Chemicals and Industrial Solutions. Management reports that measures already in place equate to about €2.0b of annual cost savings towards a €2.3b target by end 2026. The Zhanjiang Verbund ramp is feeding into petrochemicals and monomers volumes, which is central to the claim of quicker project contribution.

    However, the bullish story of earnings leverage is not yet matched by cash. Free cash flow was negative in both Q2 and the first half, with working capital and transformation spending still a clear drag.

    Access the BASF analyst estimates for BASF to see where the surface looks calm, but the multi year models start to disagree on the next potential earnings inflection point.

    BASF bear case: cash, capex and China execution

    The bearish worry around BASF is that earnings recovery rests on fragile foundations while cash, capex and China execution carry more risk than reward. Q2 backs part of that concern. EBITDA before special items is higher and guidance is raised, yet free cash flow stayed negative in both Q2 and the first half, even as transformation spending was about €200m. That weak cash conversion keeps the question of dividend coverage and self funded investment very live.

    Bears also warn that capital intensive bets and geopolitical exposure could bite. The Zhanjiang Verbund ramp is on time and under budget, which chips away at the execution fear. However, management still flags Middle East conflict, Strait of Hormuz disruption and stricter EU carbon rules as real earnings risks. With one off Coatings proceeds masking cash strain, the core caution around structurally heavier investment needs has not been disproved by these results.

    Review BASF's weak dividend coverage, debt strain and one off earnings reliance. Scan our completed risk analysis for BASF which shows 3 important warning signs for other potential structural warning signs.

    Stay Ahead With BASF Insights

    If BASF's mix of stronger EBITDA before special items and weak free cash flow has you watching for a better entry window, register for free with Simply Wall St and add it to a Watchlist so you can track price against fair value and key fundamentals in one place. After you build a position, use the Portfolio Command Center to cut through market noise and get focused alerts on earnings, cash flow trends and dividend sustainability. For a longer term view, tap into the Community to see how other investors are thinking about BASF's risks, catalysts and capital allocation. That way you can spot important shifts early, understand hidden catalysts or pressure points and stay ahead of the market with more confident decisions.

    Seeking Alternatives Beyond BASF?

    Fresh ideas move first. Some stocks are building quiet breakout momentum while others stay under the radar for now. Check these focused shortlists before the best entry windows get caught. Act now.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.